Lwcture 18 - In Vivo Flashcards

(37 cards)

1
Q

What is a pro of using animal models in drug development?

A

Whole Organism Complexity: Animal models provide an intact living system to evaluate the pharmacokinetics, pharmacodynamics, efficacy, and toxicity of drug candidates.

In vitro or in silico models cannot fully mimic these aspects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is meant by ‘Predictive Value’ in the context of animal models?

A

Historically, animal studies have helped predict human responses, including potential adverse effects.

This guides safer progression into clinical trials.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a key ethical concern related to animal models?

A

Animal welfare issues lead to social and regulatory pressure to reduce or replace animal use.

Ethical considerations are increasingly influencing research practices.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the 3Rs Principle in animal research stand for?

A

Reduce, Replace, Refine.

Aims to minimize the number of animals used and improve their welfare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the purpose of Phase 1 clinical trials?

A

Safety and dosage determination.

Involves a small group of healthy or diseased participants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fill in the blank: The _______ framework (Population, Intervention, Control, Outcome, Time) helps define the objective of an in vivo study clearly.

A

PICO(T)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the main focus of Phase 3 clinical trials?

A

Confirm therapeutic effect and safety.

Involves large, diverse patient groups and utilizes randomized, controlled designs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the PREPARE Guidelines?

A

Comprehensive planning covering study formulation, execution, and animal welfare.

Includes husbandry, housing, and handling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

True or False: Phase 4 clinical trials focus on preliminary efficacy and dosing.

A

False.

Phase 4 focuses on long-term safety, effectiveness, and rare events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a limitation of animal models in drug development?

A

Species Differences: Animal physiology and metabolism can differ from humans, leading to false positives or negatives.

This limits translational reliability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the significance of control groups and randomization in an in vivo study?

A

Minimize bias.

Proper controls and random assignment are crucial for study validity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What should be considered when selecting species for an in vivo study?

A

Ethical, biological, and practical aspects.

Relevant species to the human disease or biological system should be chosen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the focus of Phase 2 clinical trials?

A

Therapeutic exploratory: Safety, preliminary efficacy, dosing.

Involves patients with the target disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a characteristic of Phase 0 clinical trials?

A

Early microdose studies to check pharmacokinetics/pharmacodynamics.

Usually involves a small number of participants, sometimes healthy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does ‘blinding’ refer to in the context of clinical trials?

A

Preventing observer bias.

Blinding is done when possible to ensure unbiased results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the outcome focus of Phase 4 clinical trials?

A

Long-term safety, effectiveness, rare events.

These trials occur after the drug is on the market.

17
Q

What is a consequence of recent regulatory changes regarding animal testing?

A

Calls for phasing out animal testing push development of alternatives.

This reflects a growing emphasis on ethical considerations.

18
Q

What is the purpose of Phase 0 in clinical studies?

A

Early microdose studies to check PK/PD

PK stands for pharmacokinetics, and PD stands for pharmacodynamics.

19
Q

What type of participants are involved in Phase 0 studies?

A

Small number, sometimes healthy

20
Q

What are the study design characteristics of Phase 0?

A

Exploratory, low dose, sometimes first-in-human

21
Q

What is the outcome focus of Phase 0?

A

Preliminary pharmacokinetics/dynamics

22
Q

What is the main purpose of Phase 1 in clinical studies?

A

Safety and dosage

23
Q

What type of participants are involved in Phase 1 studies?

A

Small group (healthy or diseased)

24
Q

What are the study design characteristics of Phase 1?

A

Dose escalation, open-label, no controls

25
What is the outcome focus of Phase 1?
Safety, maximum tolerated dose, PK/PD
26
What is the main purpose of Phase 2 in clinical studies?
Therapeutic exploratory
27
What type of participants are involved in Phase 2 studies?
Patients with target disease
28
What are the study design characteristics of Phase 2?
Controlled or uncontrolled, may be randomized
29
What is the outcome focus of Phase 2?
Safety, preliminary efficacy, dosing
30
What is the main purpose of Phase 3 in clinical studies?
Confirm therapeutic effect and safety
31
What type of participants are involved in Phase 3 studies?
Large, diverse patient groups
32
What are the study design characteristics of Phase 3?
Randomized, controlled (placebo or standard therapy), blinding
33
What is the outcome focus of Phase 3?
Efficacy, safety, rare adverse events
34
What is the main purpose of Phase 4 in clinical studies?
Post-marketing surveillance
35
What type of participants are involved in Phase 4 studies?
Broad patient population
36
What are the study design characteristics of Phase 4?
Observational or interventional
37
What is the outcome focus of Phase 4?
Long-term safety, effectiveness, rare events